Bioline Rx Ltd Current ratio
Was ist das Current ratio von Bioline Rx Ltd?
Current ratio von Bioline Rx Ltd ist 7.12
Was ist die Definition von Current ratio?
Das derzeitige Verhältnis ist ein Liquiditätsgrad das misst, ob ein Unternehmen über ausreichende Ressourcen verfügt, um seine kurzfristigen Verpflichtungen zu erfüllen.
The current ratio is an indication of a company's liquidity and measures the capability to meet a company's short-term obligations. It compares a firm's current assets to its current liabilities, and is expressed as current assets divided by current liabilities. The ratio is only useful when two companies are compared within industry because inter industry business operations differ substantially. To determine liquidity, the current ratio is not as helpful as the quick ratio, because it includes all those assets that may not be easily liquidated, like prepaid expenses and inventory.
Acceptable current ratios vary from industry to industry. In many cases an investor would consider a high current ratio to be better than a low current ratio, because a high current ratio indicates that the company is more likely to pay the investor back. Large current ratios are not always a good sign for investors. If the company's current ratio is too high it may indicate that the company is not efficiently using its current assets or its short-term financing facilities. If current liabilities exceed current assets the current ratio will be less than 1. A current ratio of less than 1 indicates that the company may have problems meeting its short-term obligations.
Some types of businesses can operate with a current ratio of less than one however. If inventory turns into cash much more rapidly than the accounts payable become due, then the firm's current ratio can comfortably remain less than one. Inventory is valued at the cost of acquiring it and the firm intends to sell the inventory for more than this cost. The sale will therefore generate substantially more cash than the value of inventory on the balance sheet. Low current ratios can also be justified for businesses that can collect cash from customers long before they need to pay their suppliers.
Current ratio von Unternehmen in Health Care Sektor auf NASDAQ im Vergleich zu Bioline Rx Ltd
Was macht Bioline Rx Ltd?
biolinerx is a clinical-stage, publicly-traded (nasdaq/ tase: blrx) biopharmaceutical development company based in modi'in, israel. this website or social media page (the “site”) of biolinerx ltd. (the “company”) may contain content posted by a third party or links to third party websites (the “content” or “third party content”). this content is provided solely for general informational purposes as a convenience to you and not as an endorsement by the company of the content. it does not constitute a recommendation or solicitation to purchase or sell any security or make any other type of investment or investment decision. the company is not responsible for this content and does not make any representations as to the subject matter, accuracy, completeness or timeliness or the content. if you decide to access linked third party websites, you do so at your own risk. there is no warranty of any kind, express or implied, regarding the content, including without limitation any warranty of m
Unternehmen mit current ratio ähnlich Bioline Rx Ltd
- Dundee Precious Metals hat Current ratio von 7.10
- BARD1 Life Sciences hat Current ratio von 7.10
- Jewett-Cameron Trading hat Current ratio von 7.10
- Actual Experience plc hat Current ratio von 7.10
- Kubient hat Current ratio von 7.11
- Doumob hat Current ratio von 7.12
- Bioline Rx Ltd hat Current ratio von 7.12
- Immunome hat Current ratio von 7.12
- Serko hat Current ratio von 7.13
- VYNE Therapeutics hat Current ratio von 7.13
- Concepta PLC hat Current ratio von 7.13
- Compucom Software hat Current ratio von 7.13
- Provexis plc hat Current ratio von 7.14